Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Am J Ophthalmol. 2020 May 21;218:40–53. doi: 10.1016/j.ajo.2020.05.016

Table 1.

Clinical characteristics of 36 patients with optical gaps

ID Age/Sex Diagnosis Gene Variant Age of Onset BCVA (OD, OS) Symmetry
P1 26/M Stargardt ABCA4 c.4139C>T:p.Pro1380Leu,
c.5882G>A:p.Gly1961Glu
20 20/60, 20/60 Y
P2 26/F Stargardt ABCA4 c.1622T>C:p.Leu541Pro,
c.5882G>A:p.Gly1961Glu
24 N/A Y
P3 ,§ 26/F Stargardt ABCA4 c.1622T>C:p.Leu541Pro,
c.5882G>A:p.Gly1961Glu
18 20/250, 20/250 N
P4 ,§ 23/F Stargardt ABCA4 c.1622T>C:p.Leu541Pro,
c.5882G>A:p.Gly1961Glu
15 20/80, 20/80 N
P5§ 25/F Stargardt ABCA4 c.286A>G:p.Asn96Asp,
c.5882G>A:p.Gly1961Glu
24 20/40, 20/30 N
P6§ 27/F Stargardt ABCA4 c.5882G>A:p.Gly1961Glu,
c.6448T>C:p.Cys2150Arg
15 20/150, 20/150 Y
P7§ 23/M Stargardt ABCA4 c.5882G>A:p.Gly1961Glu,
c.5318C>T:p.Ala1773Val
22 20/40, 20/30 Y
P8§ 23/F Stargardt ABCA4 c.4139C>T:p.Pro1380Leu,
c.5882G>A:p.Gly1961Glu
18 20/40, 20/30 Y
P9 23/M Stargardt ABCA4 c.1622T>C:p.Leu541Pro,
c.5882G>A:p.Gly1961Glu
23 N/A N
P10 25/F Stargardt ABCA4 c.5882G>A:p.Gly1961Glu,
c.5196+1056A>G
21 20/50, 20/100 Y
P11§ 13/M Stargardt ABCA4 c.2461T>A:p.Trp821Arg,
c.6448T>C:p.Cys2150Arg
11 20/150, 20/200 Y
P12 26/M Stargardt ABCA4 c.3065A>G:p.Glu1022Gly,
c.5882G>A:p.Gly1961Glu
26 20/30, 20/30 3
P13* 30/M Achromatopsia CNGA3 c.1391T>G:p.Leu464Arg,
c.1621C>A:p.Leu541Phe
25 20/125, 20/125 Y
P14* 63/M Achromatopsia CNGA3 c.829C>T p.Arg277Cys,
c.847C>T:p.Arg283Trp
N/A 20/150, 20/150 Y
P15 45/F Achromatopsia CNGA3 c.1702G>A:p.Gly568Arg,
c.1823T>A: p.Leu608Gln
Childhood 20/100, 20/100 Y
P16* 34/M Achromatopsia CNGA3 c.830G>A:p.Arg277His,
c.1070A>G:p.Tyr357Cys
N/A 20/100, 20/150 Y
P17* 23/M Achromatopsia CNGA3 c.1391T>G:p.Leu464Arg,
c.1641C>A:p.Phe547Leu
1.5 20/50, 20/50 Y
P18 47/M Achromatopsia CNGA3 c.1669G>A:p.Gly557Arg,
c.667C>G:p.Arg223Gly
5 20/150, 20/125 Y
P19* 32/M Achromatopsia CNGB3 c.1432C>T p.Arg478Ter,
c.1432C>T p.Arg478Ter
23 20/160, 20/200 Y
P20* 46/F Achromatopsia CNGB3 c.1056–3C>G het Childhood 20/80, 20/80 Y
P21,
12/F Achromatopsia ATF6 c.970C>T:p.Arg324Cys,
c.970C>T:p.Arg324Cys
6 20/200, 20/200 Y
P22 , 23/M Achromatopsia ATF6 c.970C>T:p.Arg324Cys,
c.970C>T:p.Arg324Cys
18 20/63, 20/100 Y
P23 , 18/F Achromatopsia ATF6 c.970C>T:p.Arg324Cys,
c.970C>T:p.Arg324Cys
12 20/100, 20/63 Y
P24 32/M Achromatopsia PDE6C c.1759T>C:p.Tyr587His,
c.1759T>C:p.Tyr587His
Childhood 20/100, 20/150 Y
P25 56/F Occult Macular Dystrophy RP1L1 c.133C>T:p.Arg45Trp,
c.449C>T:p.Thr150Ile
51 20/100, 20/125 Y
P26 65/M Occult Macular Dystrophy RP1L1 c.133C>T:p.Arg45Trp 49 20/70, 20/60 Y
P27 25/M Occult Macular Dystrophy RP1L1 c.133C>T:p.Arg45Trp N/A N/A Y
P28 23/M Occult Macular Dystrophy RP1L1 c.133C>T:p.Arg45Trp 12 20/80, 20/80 Y
P29 43/F Occult Macular Dystrophy RP1L1 c.133C>T:p.Arg45Trp 33 20/60, 20/60 Y
P30 77/F Cone Dystrophy GUCA1A c.526C>T:p.Leu176Phe 45 20/125, 20/200 N
P31 66/M Macular Dystrophy GUCY2D c.2516C>T:Thr839Met 64 20/100, 20/80 Y
P32 24/F Cone Dystrophy GUCY2D c.2513G>A:p.Arg838His 24 N/A N
P33 49/F Macular Dystrophy PRPH2 c.424C<T:p.Arg142Trp Childhood 20/50, 20/50 Y
P34 56/F Macular Dystrophy PRPH2 c.514C>T p.Arg172Trp 56 20/60, 20/60 Y
P35 41/M Cone Dystrophy RAB28 c.136G>C:p.Gly46Arg,
c.70G>C: p.Gly24Arg
42 20/70, 20/70 N
P36 51/F Cone Dystrophy PITPNM3 c.227_229del:p.Gly76del 45 20/80, 20/CF N

BCVA – best corrected visual acuity, OD – right eye, OS – left eye, N/A – not available

†-

sibling pairs: P3 & P4 and P21, P22, & P23 and P27 & P28

§-

Subject previously reported by Noupuu et al.

*

Subject previously reported by Greenberg et al.

Subject previously reported by Kohl et al